Tradestie Institutional Equity Comparison Engine
XSD vs XPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XPH Overall Edge
XPH Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SPDR S&P Pharmaceuticals ETF (XPH) driven by superior Options & Structure while XSD counters with relative strength in Momentum & Technical. Fundamentally, XSD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XPH at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XSD sits in UNCLASSIFIED (12th %ile IV; Dealer Gamma Walls on Pro) against XPH sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XSD N/M vs XPH N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
XSD
1Y +35.1% vs +30.6% ยท 52W Pos 37% vs 64%
Options & Structure Winner
XPH
UNCLASSIFIED (12th %ile IV) vs UNCLASSIFIED (5th %ile IV)
XSD
NYSE Arca
SPDR S&P Semiconductor ETF
Institutional Equity
$420.62
-4.7% 1D
Market Cap
N/A
1M Return
-8.96%
1Y Return
+35.11%
Forward P/E
N/M
Unified AI Score
54.2 / 100
HOLD
Tech 70.0
Fund 58.0
Flow 50.0
Mom 58.9
XPH
NYSE Arca
SPDR S&P Pharmaceuticals ETF
Institutional Equity
$65.55
-1.92% 1D
Market Cap
N/A
1M Return
+6.0%
1Y Return
+30.55%
Forward P/E
N/M
Unified AI Score
41.0 / 100
SELL
Tech 37.0
Fund 45.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XSD +35.11%
XPH +30.55%
Spread: +4.56 pp (XSD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XSD TTM Op. Margin: N/A
XPH TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XSD vs XPH. Trailing 12-month operating profitability (XSD N/A vs XPH N/A) and valuation multiples (XSD N/M vs XPH N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XSD | XPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 37% ($281โ$658) | 64% ($50โ$74) | Stronger Trend | XPH |
| Beta / 30D Volatility Risk Regime | 2.77ฮฒ ยท 70% Vol | 0.87ฮฒ ยท 33% Vol | Lower Realized Risk | XPH |
| Unified Institutional Score Composite Signal | 54.2 / 100 (HOLD) | 41.0 / 100 (SELL) | Higher Composite | XSD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XSD vs XPH Buy Guide
XSD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
12th %ile
IV Regime
Compressed (<25th %ile)
XPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XSD nor XPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.